The US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for Intact Medical’s (IMC) Intact system.

IMC designs, develops and markets new minimally invasive systems for the excision of tissue for diagnostic and therapeutic applications in select cancer markets.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

FDA approval was secured for Intact technology’s ability to preserve breast lesion architecture in samples of up to 30mm in diameter.

"The minimally invasive system will help physicians to remove intact lesions of up to 30mm in diameter and offers several advantages, including the potential for fewer open surgical procedures."

Nashville Breast Center director Dr Pat Whitworth said: "This new FDA clearance is highly significant, not just for Intact Medical, but more importantly, for women’s health professionals and patients, globally.

"The expanded clearance recognises the unique features and significant advantages of the Intact technology, compared to core needle biopsy and open surgical excision procedures in certain situations.

See Also:

"Specifically, for small breast lesions up to 30mm in diameter, the ability of the Intact system to remove and preserve the entire lesion architecture for assessment by the pathologist combines the minimally-invasive benefits of core biopsy with the diagnostic assurances of traditional surgical excisional biopsy."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The minimally invasive system will help physicians to remove intact lesions of up to 30mm in diameter and offers several advantages, including the potential for fewer open surgical procedures.

The company said the Intact procedure can be performed in a physician’s office, with the capture of suspicious breast lesion itself completed in less than 20 seconds.